跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BE CAR-7
首页
药物
BE CAR-7
BE CAR-7
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
IMMUNOCOMPETENT CELL THAT EXPRESSES A CELL SURFACE MOLECULE SPECIFICALLY RECOGNIZING HUMAN MESOTHELIN, IL-7 AND CCL19
US 2020323920 A1
申请人: NOILE IMMUNE BIOTECH INC
优先权: 2017
CN
EP
US
5 件公开
METHOD FOR GENE TRANSFER INTO GAMMA-DELTA-TYPE T CELL
EP 3831937 A4
申请人: UNIV MIE
优先权: 2018
EP
US
WO
4 件公开
CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF
EP 4722255 A1
申请人: SHENZHEN PREGENE BIOPHARMA CO LTD
优先权: 2022
CN
EP
WO
3 件公开
COMPOSITIONS AND METHODS FOR EXPANSION OF T CELLS AND TUMOR INFILTRATING LYMPHOCYTES
US 2024075064 A1
申请人: OBSIDIAN THERAPEUTICS INC
优先权: 2021
US
WO
3 件公开
CN 116887855 A
申请人: OBSIDIAN THERAPEUTICS INC
优先权: 2021
CN
HIGHLY SELECTIVE SIGMA RECEPTOR LIGANDS
US 2011195955 A1
申请人: MCCURDY CHRISTOPHER R
优先权: 2008
US
3 件公开
US 8686008 B2
申请人: MCCURDY CHRISTOPHER R
优先权: 2010
US
3 件公开
ANTIBODY SPECIFIC FOR CD47 AND USE THEREOF
EP 4257608 A1
申请人: INNOBATION BIO CO LTD
优先权: 2020
EP
US
2 件公开
CHIMERIC ANTIGEN RECEPTOR IMMUNE CELL SPECIFICALLY BINDING TO CLAUDIN 18.2 AND USE THEREOF
WO 2025232760 A1
申请人: GRACELL BIOTECHNOLOGIES SHANGHAI CO LTD
优先权: 2024
CN
WO
2 件公开
HUMANIZED NANOBODY TARGETING CADHERIN 17 AND USE THEREOF
WO 2026066777 A1
申请人: BEIJING ROCK EDGE BIOTECHNOLOGY CO LTD
优先权: 2024
CN
WO
2 件公开
PREPARATION AND USE OF GPR87-TARGETING ALLOGENEIC CAR-γδT CELLS
WO 2026178717 A1
申请人: WEST CHINA HOSPITAL SICHUAN UNIV
优先权: 2025
CN
WO
2 件公开
Chinese medicine for treating scrofula
CN 101612164 A
申请人: RONGHUA WANG
优先权: 2009
CN
第 1 / 5 页
上一页
下一页
药物
反馈